The CD8+ T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIXTM Adjuvant
We recently described the induction of an efficient CD8+ T cell-mediated immune response against a tumor-associated antigen (TAA) uploaded in engineered exosomes used as an immunogen delivery tool. This immune response cleared tumor cells inoculated after immunization, and controlled the growth of t...
Main Authors: | Francesco Manfredi, Paola di Bonito, Barbara Ridolfi, Simona Anticoli, Claudia Arenaccio, Chiara Chiozzini, Adriana Baz Morelli, Maurizio Federico |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-11-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/4/4/42 |
Similar Items
-
N-Terminal Fatty Acids of NEF<sup>MUT</sup> Are Required for the CD8<sup>+</sup> T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
by: Chiara Chiozzini, et al.
Published: (2020-05-01) -
Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes
by: Paola Di Bonito, et al.
Published: (2019-01-01) -
Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease
by: Alessandro Ghelardi, et al.
Published: (2021-01-01) -
Comparison of the Immune Responses to Different Formulations of BC02-Adjuvanted HPV Types 16 and 18 Bivalent Vaccines in Mice
by: Junli Li, et al.
Published: (2023-09-01) -
The C-Terminal Domain of Nef<sup>mut</sup> Is Dispensable for the CD8<sup>+</sup> T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
by: Chiara Chiozzini, et al.
Published: (2021-04-01)